Reducing the impact of viral respiratory infections in children

Pediatric Clinics of North America

Volumn 52, Issue 3, 2005, Pages 695-710

  Meissner, H Cody ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMANTADINE; ANTIVIRUS AGENT; INFLUENZA VACCINE; LIVE VACCINE; OSELTAMIVIR; PALIVIZUMAB; PLECONARIL; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RIBAVIRIN; RIMANTADINE; SIALIDASE INHIBITOR; TRIPLE VACCINE; ZANAMIVIR;

ADENOVIRUS; BIOLOGICAL WARFARE; BIRD; BRONCHOSPASM; CORONAVIRUS; DISEASE SEVERITY; DNA VIRUS; EPIDEMIC; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HUMAN METAPNEUMOVIRUS; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; INFLUENZA VIRUS; LOWER RESPIRATORY TRACT INFECTION; MEDICAL RESEARCH; MOLECULAR EVOLUTION; NAUSEA; PARAINFLUENZA VIRUS; POLYMERASE CHAIN REACTION; PROPHYLAXIS; REDUCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; RISK FACTOR; RNA VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS INFECTION; VIRUS STRAIN; VOMITING;

AGE DISTRIBUTION; ANTIVIRAL AGENTS; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; COST OF ILLNESS; DIAGNOSIS, DIFFERENTIAL; ENDEMIC DISEASES; FORECASTING; HUMANS; INFANT; MORBIDITY; NEEDS ASSESSMENT; POPULATION SURVEILLANCE; PRIMARY PREVENTION; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; UNITED STATES; VACCINATION; VIRUS DISEASES;

EID: 19544362059     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2005.02.010     Document Type: Review

References (49)

1. J.A. Morris, R.E. Blount, and R.E. Savage Recovery of cytopathic agent from chimpanzees with coryza Proc Soc Exp Biol Med 92 1956 544 550
2. C.B. Hall, E.E. Walsh, and K.C. Schanbel Occurrence of groups A and B of RSV over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children J Infect Dis 162 1990 1283 1290
3. R.A. Martinello, M.D. Chen, C. Weibel, and J.S. Kahn Correlation between RSV genotype and severity of illness J Infect Dis 186 2002 839 842
4. H.C. Meissner, and S.S. Long Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infection Pediatrics 112 2003 1447 1452
5. D.K. Shay, R.C. Holman, R.D. Newman, L.L. Liu, J.W. Stoput, and L.J. Anderson Bronchiolitis associated hospitalization among United States children 1980-1996 JAMA 282 1999 1440 1446
6. D.K. Shay, R.C. Holman, G.E. Roosevelt, M.J. Clarke, and L.J. Anderson Bronchiolitis associated mortality and estimates of respiratory syncytial virus associated deaths among United States children 1979-97 J Infect Dis 183 2001 16 22
7. K.K. McCarney, M.H. Gorelick, M.L. Manning, R.I. Hodinka, and L.M. Bell Nosocomial respiratory syncytial virus infections: the cost effectiveness and cost benefit of infection control Pediatrics 106 2000 520 526
8. F.D. Martinez Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma Pediatr Infect Dis J 22 2003 S76 S82
9. H.C. Meissner, L.J. Anderson, and L.K. Pickering Annual variation in respiratory syncytial virus season and decisions regarding immunoprophylaxis with palivizumab Pediatrics 114 2004 1082 1084
10. H.C. Meissner The unresolved issue of risk factors for hospitalization of infants with respiratory syncytial virus infection born after 33-35 weeks gestation Pediatr Infect Dis J 23 2004 821 823
11. N. LeSaux, I. Gaboury, and N. MacDonald Maternal respiratory syncytial virus antibody titers: season and children matter Pediatr Infect Dis J 22 2003 563 564
12. W.P. Glezen, A. Paredes, J.E. Allison, L.H. Taber, and A.L. Frank Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group and maternal antibody level J Pediatr 98 1981 708 715
13. T.F. Feltes, A.K. Cabalka, H.C. Meissner and Cardiac Synagis study group Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease J Pediatr 143 2003 532 540
14. H.C. Meissner Selected populations at increased risk from respiratory syncytial virus infection Pediatr Infect Dis J 22 2003 S40 S45
15. J.A. Mullins, A.C. Lamonte, J.S. Bresee, and L.J. Anderson Substantial variability in community respiratory syncytial virus season timing Pediatr Infect Dis J 22 2003 857 862
16. A.P. Durbin, and R.A. Karron Progress in the development of RSV and parainfluenza virus vaccines Clin Infect Dis 37 2003 1668 1677
17. S. Johnson, C. Oliver, and G.A. Prince Development of humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus J Infect Dis 176 1997 1215 1224
18. The IMpact-RSV study group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants Pediatrics 102 1998 531 537
19. J.R. Romero Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage Pediatr Infect Dis J 22 2003 S46 S54
20. H.C. Meissner, R.C. Welliver, and S.A. Chartrand Immunoprophylaxis with palivizumab, a humanized RSV monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion Pediatr Infect Dis J 18 1999 223 231
21. E.A.F. Simoes Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease J Pediatr 143 2003 S118 S126
22. American Academy of Pediatrics Revised indications of the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections Pediatrics 112 2003 1442 1446
23. Centers for Disease Control and Prevention Prevention and control of influenza MMWR Morb Mortal Wkly Rep 52 RR-8 2003 1 36
24. H.S. Izurieta, W.W. Thompson, and P. Kramarz Influenza and the rates of hospitalizations for respiratory disease among infants and young children N Engl J Med 342 2000 232 239
25. K.M. Neuzil, B.G. Mellen, P.E. Wright, E.F. Mitchel, and M.R. Griffin The effect of influenza on hospitalizations, outpatient visits and courses of antibiotic in children N Engl J Med 342 2000 225 231
26. M.B. Rennels, and H.C. Meissner Reduction of the influenza burden in children Pediatrics 110 2002 e80 e98
27. J. Weitkamp, M.D. Spring, and T. Brogan Influenza A virus-associated acute necrotizing encephalopathy in the United States Pediatr Infect Dis J 23 2004 259 263
28. R.B. Belshe, W.C. Gruber, and P.M. Mendelman Efficacy of vaccination with live attenuated cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine J Pediatr 136 2000 168 175
29. Centers for Disease Control and Prevention Neuraminidase inhibitors for treatment of influenza A and B infections MMWR Morb Mortal Wkly Rep 48 RR-14 1999 1 9
30. J.A. Hedrick, A. Barzilai, and U. Behre Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial Pediatr Infect Dis J 19 2000 410 417
31. R.J. Whitely, F.G. Hayden, and K.S. Reisinger Oral oseltamivir treatment of influenza in children Pediatr Infect Dis J 20 2001 127 133
32. R. Welliver, A.S. Monto, and O. Carewicz Effectiveness of oseltamivir in preventing influenza in household contacts JAMA 285 2001 748 754
33. F.G. Hayden, L.V. Gubareva, and A.S. Monto Inhaled zanamivir for the prevention of influenza in families N Engl J Med 343 2000 1282 1289
34. B.G. van den Hoogen, J.C. deJong, and J. Groen A newly discovered human pneumovirus isolated from young children with respiratory tract disease Nat Med 7 2001 719 724
35. J.A. Mullins, D.D. Erdman, and G.A. Weinberg Human metapneumovirus infection among children hospitalized with acute respiratory illness Emerg Infect Dis 10 2004 700 705
36. J.V. Williams, P.A. Harris, and S.J. Tollefson Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children N Engl J Med 350 2004 443 450
37. B.G. van den Hoogen, M.E. Osterhaus, and R.A.M. Pouchier Clinical impact and diagnosis of human metapneumovirus infection Pediatr Infect Dis J 23 2004 S25 S32
38. K.J. Henrickson Parainfluenza viruses Clin Microbiol Rev 16 2003 242 264
39. A.M. Knott, C.E. Long, and C.B. Hall Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics Pediatr Infect Dis J 13 1994 269 273
40. G. Reed, P.H. Jewett, J. Thompson, S. Tollefson, and P.F. Wright Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old J Infect Dis 175 1997 807 813
41. R.A. Karron, R.B. Belshe, and P.F. Wright A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants Pediatr Infect Dis J 22 2003 394 405
42. B.B. Belshe, F.K. Newman, and E.L. Anderson Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children J Infect Dis 190 2004 2096 2103
43. T.G. Ksiazek, D. Erdman, and C.S. Goldsmith A novel coronavirus associated with severe acute respiratory syndrome N Engl J Med 348 2003 1953 1966
44. J.S.M. Peris, K.Y. Yeun, A.D.M.E. Osterhaus, and K. Stohr The acute respiratory syndrome N Engl J Med 349 2003 2431 2441
45. C. Leung, Y. Kwan, and P. Ko Severe acute respiratory syndrome in children Pediatrics 113 2004 e535 e543
46. S.L. Katz A tale of two vaccines Clin Infect Dis 31 2000 671 672
47. E. Arruda, A. Pitkaranta, T.J. Witek, C.A. Doyle, and F.G. Hayden Frequency and natural history of rhinovirus infections in adults during autumn J Clin Microbiol 35 1997 2864 2868
48. M.R. Griffin, F.J. Walker, M.K. Iwane, G.A. Weinberg, M.A. Staat, D.D. Erdman and the New Vaccine Surveillance Network Study Group Epidemiology of respiratory infections in young children: insights from the New Vaccine Surveillance Network Pediatr Infect Dis J 23 2004 S193 S201
49. M.K. Iwane, K.M. Edwards, and P.G. Szilagyi Population-based surveillance for hospitalizations associated with RSV, influenza virus, and parainfluenza viruses among young children Pediatrics 113 2004 1758 1764